Skip to main content

Ferric Carboxymaltose News

Guidelines Developed for Treatment of Restless Legs Syndrome

MONDAY, Dec. 2, 2024 – In a clinical practice guideline issued by the American Academy of Sleep Medicine and published online Sept. 26 in the Journal of Clinical Sleep Medicine, recommendations are ...

Injectafer Approved in the U.S. for the Treatment of Iron Deficiency in Adult Patients with Heart Failure

BASKING RIDGE, N.J. & SHIRLEY, N.Y.--(BUSINESS WIRE) June 05, 2023 --Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug...

Injectafer (ferric carboxymaltose injection) Receives FDA Approval for Single Dose Option for the Treatment of Adult Patients with Iron Deficiency Anemia

BASKING RIDGE, N.J. and SHIRLEY, N.Y., May 6, 2021 /PRNewswire/ – Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug Adm...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Iron Deficiency Anemia

Ferric Carboxymaltose patient information at Drugs.com